ELV

Elevance Health Inc

ELV, USA

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. It also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, the company provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. It provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

https://www.elevancehealth.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

Quarterly

Rate:

1.71

Next Payout:

Dec 19, 2025

Yield:

1.9049 %
ELV
stock
ELV

Is Elevance Health (ELV) Quietly Repricing Its Risk Profile With Ratings Wins And AI Expansion? simplywall.st

Read more →
ELV
stock
ELV

Liontrust Investment Partners LLP Reduces Stock Position in Elevance Health, Inc. $ELV MarketBeat

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$387.1579

Analyst Picks

Strong Buy

13

Buy

5

Hold

4

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

Very High

13.80

Low 50

High 10

Price to Book Ratio (P/B)

-

Medium

1.84

Low 1

High 3

Return on Equity (ROE)

-

Very Low

2.71 %

Low 5%

High 25%

Return on Assets (ROA)

-

Very Low

0.97 %

Low 2%

High 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

1.53 %

Low 5%

High 15%

Debt to Equity

-

Very Low

1.79

Low 1

High 0.3

Investors

* Institutions hold a combined 73.77% of the total shares of Elevance Health Inc

1.

Vanguard Group Inc

(10.1506%)

since

2025/06/30

2.

BlackRock Inc

(9.4641%)

since

2025/03/31

3.

State Street Corp

(4.7286%)

since

2025/03/31

4.

T. Rowe Price Associates, Inc.

(3.5906%)

since

2025/06/30

5.

Vanguard Total Stock Mkt Idx Inv

(3.1535%)

since

2025/07/31

6.

Capital Research & Mgmt Co - Division 3

(2.8813%)

since

2025/06/30

7.

Wellington Management Company LLP

(2.8059%)

since

2025/06/30

8.

Sanders Capital, LLC

(2.5869%)

since

2025/06/30

9.

Vanguard 500 Index Investor

(2.4836%)

since

2025/07/31

10.

Geode Capital Management, LLC

(2.2945%)

since

2025/03/31

11.

Artisan Partners Limited Partnership

(1.6321%)

since

2025/06/30

12.

Arnhold & S. Bleichroeder Advisers, LLC

(1.4212%)

since

2025/06/30

13.

UBS Asset Mgmt Americas Inc

(1.3231%)

since

2025/06/30

14.

Morgan Stanley - Brokerage Accounts

(1.3203%)

since

2025/03/31

15.

NORGES BANK

(1.3112%)

since

2025/06/30

16.

Fidelity 500 Index

(1.2719%)

since

2025/07/31

17.

Orbis Allan Gray Ltd

(1.2683%)

since

2025/06/30

18.

iShares Core S&P 500 ETF

(1.2072%)

since

2025/08/29

19.

SPDR® S&P 500® ETF

(1.195%)

since

2025/08/29

20.

First Eagle Global A

(1.1413%)

since

2025/07/31

21.

Northern Trust Corp

(1.0846%)

since

2025/03/31

22.

Massachusetts Financial Services Company

(1.0341%)

since

2025/06/30

23.

Harris Associates L.P.

(1.0159%)

since

2025/06/30

24.

Baillie Gifford & Co Limited.

(0.9934%)

since

2025/06/30

25.

Capital Group Wash Mutual Invtrs Comp

(0.9878%)

since

2025/06/30

26.

American Funds Washington Mutual A

(0.9878%)

since

2025/06/30

27.

Bank of America Corp

(0.9791%)

since

2025/03/31

28.

Loomis Sayles Long Corp Disc Alpha

(0.9712%)

since

2025/06/30

29.

Amvescap Plc.

(0.9398%)

since

2025/03/31

30.

Vanguard Value Index Inv

(0.8893%)

since

2025/07/31

31.

Vanguard Equity-Income Inv

(0.8243%)

since

2025/06/30

32.

Vanguard Health Care Inv

(0.7551%)

since

2025/06/30

33.

MFS Large Cap Value Equity

(0.7465%)

since

2025/06/30

34.

MFS Value A

(0.7421%)

since

2025/07/31

35.

Vanguard Windsor™ II Inv

(0.7164%)

since

2025/06/30

36.

The Health Care Select Sector SPDR® ETF

(0.684%)

since

2025/08/29

37.

Vanguard Institutional Index I

(0.6065%)

since

2025/07/31

38.

Vanguard Dividend Appreciation ETF

(0.5391%)

since

2025/07/31

39.

State St S&P 500® Indx SL Cl III

(0.5364%)

since

2025/07/31

40.

T. Rowe Price U.S. Value Equity Tr-D

(0.5019%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

No earnings data available.

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(5.5)
Defensive
Highly Defensive(7)
Dividend
Decent Dividend Payer(4)
Economic Moat
Wide Moat Company(6.3)
GARP
Not Attractive for GARP(3)
Growth
Weak Growth Prospect(3)
Momentum
Moderate Momentum(4)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Moderate Quality(5)
Value
Fair Value(6)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.